Financial statements Vertex Pharmaceuticals (Poland)
Balance sheet of Vertex Pharmaceuticals (Poland)
Company age:
Age:
7 y. 10 m. 8 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of VERTEX PHARMACEUTICALS (POLAND)
|
Year
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|
| Total assets | 4 055 925,00 | 4 142 664,00 | 5 576 156,00 | 8 877 261,53 |
| A. Fixed assets | 45 272,00 | 34 824,00 | 24 377,00 | 86 376,49 |
| B. Current assets | 4 010 653,00 | 4 107 840,00 | 5 551 779,00 | 8 790 885,04 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 4 055 925,00 | 4 142 664,00 | 5 576 156,00 | 8 877 261,53 |
| A. Equity | 949 077,00 | 1 169 175,00 | 1 909 196,00 | 2 821 879,81 |
| B. Liabilities and provisions for liabilities | 3 106 848,00 | 2 973 489,00 | 3 666 960,00 | 6 055 381,72 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 1 990 340,00 | 1 523 200,00 | 1 884 188,00 | 4 172 307,85 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.